New Hampshire HB 656: establishing a committee to study the impact of financial initiatives for commercially insured members by drug manufacturers on prescription drug prices and health insurance premiums.

Status: Signed by Governor Sununu 07/19/2019; Chapter 267; Eff: 07/19/2019 (as of 2019-07-24)

State: New Hampshire · Session: 2019 · Bill: HB 656

View New Hampshire HB 656 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.